← Back to Search

Behavioral Intervention

Memory Improvement Technique for Aging

N/A
Waitlist Available
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Current use of benzodiazepines and steroids
History of prior stroke or neurological injury/disease (e.g., traumatic brain injury, Multiple Sclerosis, or Stroke)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three points in time: pre-treatment, immediately following treatment, and 6- months after treatment is completed]

Summary

This trial aims to see if a memory improvement technique works well for older people.

Who is the study for?
This trial is for English-speaking adults who are experiencing normal aging or have mild cognitive impairment (MCI). It's not suitable for those with a history of significant psychiatric illness, alcohol or drug abuse requiring inpatient treatment, current use of benzodiazepines and steroids, prior stroke, neurological injury/disease, or dementia.
What is being tested?
The study is testing a memory enhancement technique called STEM. The goal is to see if this method can improve new learning and memory in individuals who are aging healthily as well as those with MCI.
What are the potential side effects?
Since the intervention involves a non-invasive educational technique focused on memory improvement, no direct physical side effects are expected from participating in this trial.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently taking benzodiazepines and steroids.
Select...
I have had a stroke or a neurological condition like MS or brain injury.
Select...
I have been diagnosed with dementia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three points in time: pre-treatment, immediately following treatment, and 6- months after treatment is completed]
This trial's timeline: 3 weeks for screening, Varies for treatment, and three points in time: pre-treatment, immediately following treatment, and 6- months after treatment is completed] for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Participation in Everyday life
Verbal Leaning task
Secondary study objectives
Functional Neuroimaging

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental groupExperimental Treatment1 Intervention
The experimental group will receive memory techniques training administered twice a week for four weeks (8 training sessions).
Group II: Control groupPlacebo Group1 Intervention
The control group will receive memory exercises administered twice a week for four weeks (8 sessions).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STEM
2019
N/A
~1030

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
182 Previous Clinical Trials
11,053 Total Patients Enrolled
1 Trials studying Aging
33 Patients Enrolled for Aging
~13 spots leftby Mar 2025